Publications
January 2021
October 2020
Technology and Liability of the Managing Director
June 2020
July 2018
Patentverletzung im Hinblick auf den 3D-Druck und Geschäftsführerhaftung
Author: Dr. Marc Gerauer
June 2018
Das CRISPR/Cas-System - Der nächste Quantensprung in der Molekularbiologie
Author: Dr. Oliver Ladendorf
May 2017
Patentability of products obtained by essentially biological processes in Europe
Authors: Dr. Oliver Ladendorf, Dr. Evy Corbanie
April 2016
What is the relevant date of marketing authorization to determine the term of an SPC?
Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen
April 2016
May a part of a fusion protein be considered an "active ingredient"?
Yes, says the ECJ in Forsgren
Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen
March 2016
Eli Lilly vs. HGS (C-493/12):
The UK High Court clarifies the ECJ's enigmatic decision
Authors: Dr. Oliver Ladendorf, Dr. Alexander Kleefen
Contact
KRAUS & WEISERT
Patentanwälte PartGmbB
European Patent and Trademark Attorneys
Thomas-Wimmer-Ring 15 | 80539 Munich | Germany
T +49 89 29060 - 0 | F +49 89 29060 - 111
www.kraus-weisert.de | This email address is being protected from spambots. You need JavaScript enabled to view it.
Proud to be honoured
We have received awards from renowned national and international handbooks, magazines, newspapers and international professional journals and are proud when good work is recognized.
News
Kraus & Weisert filed the first opt-out request in history
On March 1, 2023 the sunrise period for opting out EP patents and applications from the UPC’s jurisdiction started. Kraus & Weisert is pleased to announce that it filed the first three opt-out requests in the history of the UPC.
Germany has ratified the Agreement on a Unified Patent Court
On February 17, 2023 the Federal Ministry of Justice announced that Germany has ratified the Agreement on the Unified Patent Court.
of the Boards of Appeal